5-fluoro- and 8-fluoro-trimetoquinol compounds and the processes

Organic compounds -- part of the class 532-570 series – Organic compounds – Nitriles

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

558332, 558350, 564389, C07C12000, C07C12166

Patent

active

048554766

ABSTRACT:
The present invention relates to novel 5-fluoro- and 8-fluoro-trimetoquinol compounds of the general formula I wherein X.sub.1 =F, X.sub.2 =H or X.sub.1 =H, X.sub.2 =F ##STR1## The present invention also relates to a process for making the 5-fluoro- and 8-fluoro-trimetoquinol compounds by condensation of an appropriately substituted phenethylamine to afford an appropriately substituted phenlethylacetamide compound. The amides are cyclized to give appropriately substituted intermediate dihydroisoquinolines. Without isolation, the dihydroisoquinolines are reduced to give appropriately substituted tetrahydroisoquinolines. The hydrochloride salts of tetrahydroisoquinolines are prepared and subjected to hydrogenolysis, to give the fluorine substituted trimetoquinol compounds of the present invention. The present invention also encompasses the preparation of the phenethylamines by reducing appropriately substituted benzylcyanides and to the preparation of an intermediate benzylcyanide compound by converting a fluorine substituted methoxyphenol compound, under aminomethylation conditions into a N-N-dimethyl-4-hydroxy-3-methoxy-5-fluorobenzylamine. The benzylamine is converted to benzylnitrile and a functional group shuffle is carried out which yields the appropriately substituted benzylcyanide compound. In a composition aspect, the present invention encompasses novel pharmaceutical compositions comprising a compound of the formula I, together with a physiologically acceptable carrier or excipient, in an amount sufficient to increase .beta..sub.2 -adrenergic and antithrombotic activities while simultaneously decreasing the .beta..sub.1 -adrenergic activity in mammals, including humans. The compounds of the invention are useful in the treatment of pulmonary, cardiovascular or thromboembolic disorders.

REFERENCES:
patent: 4737504 (1988-04-01), Miller et al.
Kirk et al., J. Med. Chem., 22, 1493-1497 (1979).
Miller et al., J. Med. Chem., 19:763-766 (1976).
Osei-Gyimah et al., J. Med. Chem., 21:1173-1178 (1978).
Piascik et al., Biochem. Pharmacol., 28:1807-1810 (1979).
Piascik et al., Life Sci., 24:2433-2439 (1979).
Mukhopadhyay et al., Eur. J. Pharmacol., 77:209-219 (1982).
Mukhopadhyay et al., J. Pharmacol. Exp., 232:1-9 (1985).
Cantacuzene et al., Science, 204, 1217-1219 (1979).
Kirk-Othmer: Encyclopedia of Chemical Technology, vol. 2, Third Edition, Copyright 1978 by John Wiley & Sons, Inc., pp. 757-782.
Yamada et al., "Chemical Abstracts", vol. 96, 1982, Col. 96:85389p.
Clark et al., "Chemical Abstracts", vol. 106, 1987, Col. 106:49995z.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5-fluoro- and 8-fluoro-trimetoquinol compounds and the processes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-fluoro- and 8-fluoro-trimetoquinol compounds and the processes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-fluoro- and 8-fluoro-trimetoquinol compounds and the processes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-907029

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.